Methotrexate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

44 Suppliers, 20 USDMF, 7 CEP/COS, 4 JDMF, 3 EU WC, 9 NDC API, 23 Listed Suppliers

DEVELOPMENTS

53 Drug(s) in Development

53 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

6 Suppliers

6 Suppliers

DOSSIERs // Finished Dosage Forms

563 Dossiers, 126 FDA Orange Book, 289 Europe, 38 Canada, 45 Australia, 12 South Africa, 53 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL, INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML), INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML), INJECTABLE;INJECTION - EQ 2.5MG BASE/ML, INJECTABLE;INJECTION - EQ 20MG BASE/VIAL, INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML), INJECTABLE;INJECTION - EQ 25MG BASE/ML, INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 50MG BASE/VIAL, INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML), SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML), SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML), SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML), SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML), SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML), SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML), SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML), SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML), TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 17 Roquette, 17 BASF, 13 Seppic, 11 Microlex e.U, 11 Sigachi Industries, 10 Corel Pharma Chem, 9 Gangwal Chemicals, 9 Gangwal Healthcare, 9 Actylis, 6 Lonza Capsugel, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DFE Pharma, 5 Ideal Cures Pvt Ltd, 5 Nanjing Well Pharmaceutical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 SPI Pharma, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Finar, 2 Seqens, 2 Nomisma Healthcare, 2 Pharmatrans-Sanaq, 2 The Dow Chemical Company, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Jai Radhe Sales, 1 Clariant, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Rochem International Inc, 1 Pharm-RX Chemical, 1 Aeon Procare, 1 DKSH, 1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

55 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 28 Direct Compression, 26 Controlled & Modified Release, 20 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 18 Granulation, 17 Solubilizers, 16 Topical, 15 Lubricants & Glidants, 14 Parenteral, 13 Co-Processed Excipients, 11 Film Formers & Plasticizers, 11 Taste Masking, 6 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

47 US Medicaid Prescriptions, 188 Finished Drug Prices

MARKET PLACE

16 APIs, 23 DOSSIERS // FDF

PATENTS

135 US Patents, 2 US Exclusivities

ANALYTICAL SOLUTION(s)

6 EDQM Standards, 5 USP Standards, 4 JP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 117 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Methotrexate. Original Data : Therapeutic Goods Administration Website

Methotrexate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

44 Suppliers

20 USDMF

7 CEP/COS

4 JDMF

3 EU WC

9 NDC API

23 Listed Suppliers

DEVELOPMENTS

53 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

6 Suppliers

DOSSIERs // Finished Dosage Forms

563 Dossiers

126 FDA Orange Book

289 Europe

38 Canada

45 Australia

12 South Africa

53 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL

INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)

INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)

INJECTABLE;INJECTION - EQ 2.5MG BASE/ML

INJECTABLE;INJECTION - EQ 20MG BASE/VIAL

INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)

INJECTABLE;INJECTION - EQ 25MG BASE/ML

INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 50MG BASE/VIAL

INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)

SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)

SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)

SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)

SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)

SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)

SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)

SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)

SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)

TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

17 Roquette

17 BASF

13 Seppic

11 Microlex e.U

11 Sigachi Industries

10 Corel Pharma Chem

9 Gangwal Chemicals

9 Gangwal Healthcare

9 Actylis

6 Lonza Capsugel

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DFE Pharma

5 Ideal Cures Pvt Ltd

5 Nanjing Well Pharmaceutical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 SPI Pharma

3 Prachin Chemical

3 Vasa Pharmachem

3 Ingredion Pharma Solutions

3 Kima Chemical

3 Finar

2 Seqens

2 Nomisma Healthcare

2 Pharmatrans-Sanaq

2 The Dow Chemical Company

1 Qianhao Chemical (Hebei) Co., Ltd

INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons